Intestinal Bacteria Condition Dendritic Cells to Promote IgA Production

被引:83
作者
Massacand, Joanna C. [1 ]
Kaiser, Patrick [1 ]
Ernst, Bettina [2 ]
Tardivel, Aubry [3 ]
Buerki, Kurt [4 ]
Schneider, Pascal [3 ]
Harris, Nicola L. [1 ]
机构
[1] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland
[2] Swiss Fed Inst Technol, Inst Integrative Biol, Mol Biomed, Zurich, Switzerland
[3] Univ Lausanne, Dept Biochem, Epalinges, Switzerland
[4] Univ Zurich, Inst Lab Anim Sci, Zurich, Switzerland
来源
PLOS ONE | 2008年 / 3卷 / 07期
基金
瑞士国家科学基金会;
关键词
D O I
10.1371/journal.pone.0002588
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Immunoglobulin (Ig) A represents the predominant antibody isotype produced at the intestinal mucosa, where it plays an important role in limiting the penetration of commensal intestinal bacteria and opportunistic pathogens. We show in mice that Peyer's Patch-derived dendritic cells (PP-DC) exhibit a specialized phenotype allowing the promotion of IgA production by B2 cells. This phenotype included increased expression of the retinaldehyde dehydrogenase 1 (RALDH1), inducible nitric oxide synthase (iNOS), B cell activating factor of the tumor necrosis family (BAFF), a proliferation-inducing ligand (APRIL), and receptors for the neuropeptide vasoactive intestinal peptide (VIP). The ability of PP-DC to promote anti-CD40 dependent IgA was partially dependent on retinoic acid (RA) and transforming growth factor (TGF)-beta, whilst BAFF and APRIL signaling were not required. Signals delivered by BAFF and APRIL were crucial for CD40 independent IgA production, although the contribution of B2 cells to this pathway was minimal. The unique ability of PP-DC to instruct naive B cells to differentiate into IgA producing plasma cells was mainly imparted by the presence of intestinal commensal bacteria, and could be mimicked by the addition of LPS to the culture. These data indicate that exposure to pathogen-associated molecular patterns present on intestinal commensal bacteria condition DC to express a unique molecular footprint that in turn allows them to promote IgA production.
引用
收藏
页数:9
相关论文
共 58 条
[1]   Gut IgA class switch recombination in the absence of CD40 does not occur in the lamina propria and is independent of germinal centers [J].
Bergqvist, Peter ;
Gardby, Eva ;
Stensson, Anneli ;
Bemark, Mats ;
Lycke, Nils Y. .
JOURNAL OF IMMUNOLOGY, 2006, 177 (11) :7772-7783
[2]   Nitric oxide and the immune response [J].
Bogdan, C .
NATURE IMMUNOLOGY, 2001, 2 (10) :907-916
[3]   VASOACTIVE INTESTINAL POLYPEPTIDE MODULATES THE IN-VITRO IMMUNOGLOBULIN-A PRODUCTION BY INTESTINAL LAMINA PROPRIA LYMPHOCYTES [J].
BOIRIVANT, M ;
FAIS, S ;
ANNIBALE, B ;
AGOSTINI, D ;
FAVE, GD ;
PALLONE, F .
GASTROENTEROLOGY, 1994, 106 (03) :576-582
[4]   DIRECT EVIDENCE FOR AN INTEGRATED FUNCTION OF J-CHAIN AND SECRETORY COMPONENT IN EPITHELIAL TRANSPORT OF IMMUNOGLOBULINS [J].
BRANDTZAEG, P ;
PRYDZ, H .
NATURE, 1984, 311 (5981) :71-74
[5]  
Brandtzaeg P, 1994, HDB MUCOSAL IMMUNOLO, P113
[6]   TACI and BAFF-R mediate isotype switching in B cells [J].
Castigli, E ;
Wilson, SA ;
Scott, S ;
Dedeoglu, F ;
Xu, SL ;
Lam, KP ;
Bram, RJ ;
Jabara, H ;
Geha, RS .
JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (01) :35-39
[7]   A MICROCULTURE CONTAINING-TH2 AND DENDRITIC CELLS SUPPORTS THE PRODUCTION OF IGA BY CLONES FROM BOTH PRIMARY AND IGA MEMORY B-CELLS AND BY SINGLE GERMINAL CENTER B-CELLS FROM PEYER PATCHES [J].
CEBRA, JJ ;
GEORGE, A ;
SCHRADER, CE .
IMMUNOLOGIC RESEARCH, 1991, 10 (3-4) :389-392
[8]  
CEBRA JJ, 1995, ADV EXP MED BIOL, V371, P429
[9]   Regulation of dendritic cell differentiation by vasoactive intestinal peptide - Therapeutic applications on autoimmunity and transplantation [J].
Chorny, Alejo ;
Gonzalez-Rey, Elena ;
Delgado, Mario .
NEUROENDOCRINE AND IMMUNE CROSSTALK, 2006, 1088 :187-194
[10]   TRANSFORMING GROWTH FACTOR-BETA SPECIFICALLY ENHANCES IGA PRODUCTION BY LIPOPOLYSACCHARIDE-STIMULATED MURINE LYMPHOCYTES-B [J].
COFFMAN, RL ;
LEBMAN, DA ;
SHRADER, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :1039-1044